EP2224806A4 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
EP2224806A4
EP2224806A4 EP08862226.1A EP08862226A EP2224806A4 EP 2224806 A4 EP2224806 A4 EP 2224806A4 EP 08862226 A EP08862226 A EP 08862226A EP 2224806 A4 EP2224806 A4 EP 2224806A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08862226.1A
Other languages
German (de)
French (fr)
Other versions
EP2224806A1 (en
Inventor
Alfred Liang
Frank Matthews
Garth Boehm
Lijuan Tang
Frank Johnson
Joseph Stauffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpharma Pharmaceuticals LLC
Original Assignee
Alpharma Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US788207P priority Critical
Application filed by Alpharma Pharmaceuticals LLC filed Critical Alpharma Pharmaceuticals LLC
Priority to PCT/US2008/087030 priority patent/WO2009079518A1/en
Publication of EP2224806A1 publication Critical patent/EP2224806A1/en
Publication of EP2224806A4 publication Critical patent/EP2224806A4/en
Application status is Withdrawn legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
EP08862226.1A 2007-12-17 2008-12-16 Pharmaceutical composition Withdrawn EP2224806A4 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US788207P true 2007-12-17 2007-12-17
PCT/US2008/087030 WO2009079518A1 (en) 2007-12-17 2008-12-16 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
EP2224806A1 EP2224806A1 (en) 2010-09-08
EP2224806A4 true EP2224806A4 (en) 2014-02-19

Family

ID=40795902

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08862226.1A Withdrawn EP2224806A4 (en) 2007-12-17 2008-12-16 Pharmaceutical composition

Country Status (4)

Country Link
EP (1) EP2224806A4 (en)
AU (1) AU2008338439A1 (en)
CA (1) CA2709903A1 (en)
WO (1) WO2009079518A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL151057D0 (en) 2000-02-08 2003-04-10 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
AU2008343267A1 (en) * 2007-12-17 2009-07-09 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
EP2224808A4 (en) * 2007-12-17 2013-11-27 Alpharma Pharmaceuticals Llc Pharmaceutical composition

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033566A2 (en) * 1996-03-12 1997-09-18 Alza Corporation Composition and dosage form comprising opioid antagonist
WO2001058451A1 (en) * 2000-02-08 2001-08-16 Euro-Celtique, S.A. Tamper-resistant oral opioid agonist formulations
WO2004026283A1 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sequestering subunit and related compositions and metohds
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20050191244A1 (en) * 2002-10-25 2005-09-01 Gruenenthal Gmbh Abuse-resistant pharmaceutical dosage form
US20070269505A1 (en) * 2003-12-09 2007-11-22 Flath Robert P Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
WO2007149438A2 (en) * 2006-06-19 2007-12-27 Alpharma, Inc. Pharmaceutical compositions
WO2008027442A2 (en) * 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
WO2008063301A2 (en) * 2006-10-11 2008-05-29 Alpharma, Inc. Pharmaceutical compositions
WO2009032270A2 (en) * 2007-09-04 2009-03-12 Alpharma, Inc. A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
WO2009085778A1 (en) * 2007-12-17 2009-07-09 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
WO2007013975A2 (en) * 2005-07-20 2007-02-01 Pharmorx Inc. Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033566A2 (en) * 1996-03-12 1997-09-18 Alza Corporation Composition and dosage form comprising opioid antagonist
WO2001058451A1 (en) * 2000-02-08 2001-08-16 Euro-Celtique, S.A. Tamper-resistant oral opioid agonist formulations
WO2004026283A1 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sequestering subunit and related compositions and metohds
US20050191244A1 (en) * 2002-10-25 2005-09-01 Gruenenthal Gmbh Abuse-resistant pharmaceutical dosage form
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20070269505A1 (en) * 2003-12-09 2007-11-22 Flath Robert P Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
WO2007149438A2 (en) * 2006-06-19 2007-12-27 Alpharma, Inc. Pharmaceutical compositions
WO2008027442A2 (en) * 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
WO2008063301A2 (en) * 2006-10-11 2008-05-29 Alpharma, Inc. Pharmaceutical compositions
WO2009032270A2 (en) * 2007-09-04 2009-03-12 Alpharma, Inc. A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer
WO2009085778A1 (en) * 2007-12-17 2009-07-09 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
WO2009088673A2 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOHNSON F ET AL: "(236) Relative bioavailability of plasma naltrexone from crushed ALO-01 (an investigational, abuse-deterrent, extended-release, morphine sulfate formulation with sequestered naltrexone) to a naltrexone oral solution", JOURNAL OF PAIN, SAUNDERS, PHILADELPHIA, PA, US, vol. 9, no. 4, 1 April 2008 (2008-04-01), pages 35, XP025871409, ISSN: 1526-5900, [retrieved on 20080401], DOI: 10.1016/J.JPAIN.2008.01.157 *
See also references of WO2009079518A1 *

Also Published As

Publication number Publication date
AU2008338439A1 (en) 2009-06-25
CA2709903A1 (en) 2009-06-25
EP2224806A1 (en) 2010-09-08
WO2009079518A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
TWI609702B (en) Layered pharmaceutical formulations
TWI428126B (en) Pharmaceutical composition for external use
EP2219637A4 (en) Avenanthramide-containing compositions
IL194762D0 (en) Pharmaceutical compounds
EP2001498A4 (en) Pharmaceutical compositions
GB0718777D0 (en) Composition
ZA200810501B (en) Pharmaceutical compositions
IL194176D0 (en) Pharmaceutical compositions
TWI389686B (en) Pharmaceutical composition for external use
ZA201104336B (en) Pharmaceutical compounds
GB0709031D0 (en) Pharmaceutical compounds
EP2240022A4 (en) Pharmaceutical compositions
GB0724342D0 (en) Anitbacterial compositions
ZA200808530B (en) Pharmaceutical composition for external use
IL199656D0 (en) Tablet-in-tablet compositions
GB0608820D0 (en) Pharmaceutical compounds
GB0814695D0 (en) Pharmaceutical compositions
IL201366D0 (en) Pharmaceutical compounds
IL237392D0 (en) Pharmaceutical combination
GB0713625D0 (en) Pharmaceutical compositions
EP1982718A4 (en) Anti-cancer pharmaceutical composition
IL215451D0 (en) Pharmaceutical composition
EP2204157A4 (en) Two-pack hairdye composition
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
EP2191826A4 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent to

Countries concerned: ALBAMKRS

17P Request for examination filed

Effective date: 20100624

RIN1 Inventor (correction)

Inventor name: MATTHEWS, FRANK

Inventor name: LIANG, ALFRED

Inventor name: BOEHM, GARTH

Inventor name: TANG, LIJUAN

Inventor name: JOHNSON, FRANK

Inventor name: STAUFFER, JOSEPH

DAX Request for extension of the european patent (to any country) deleted
RIC1 Classification (correction)

Ipc: A61K 31/485 20060101ALI20140116BHEP

Ipc: A61K 9/50 20060101AFI20140116BHEP

A4 Despatch of supplementary search report

Effective date: 20140122

18D Deemed to be withdrawn

Effective date: 20140819